Hot Stocks to Follow for Investment Opportunity & Special Profile
November 06 2014 - 6:00AM
InvestorsHub NewsWire
Alibaba Group Holding Limited (NYSE:
BABA) is the largest online and mobile commerce company in the
world in terms of gross merchandise volume. The company provides
the fundamental technology infrastructure and marketing reach to
help businesses leverage the power of the Internet to establish an
online presence and conduct commerce with hundreds of millions of
consumers and other businesses.
After the company’s stunning IPO on the NYSE earlier this year, the
BABA seems to be continuing its financial success. Read the details
in the report at the link: http://bit.ly/-BABA--AnalystReport
Northwest Biopharmaceutics, Inc. (NASDAQ:
NWBO) is a biotechnology company focused on developing
immunotherapy products to treat cancers more effectively than
current treatments, without toxicities of the kind associated with
chemotherapies, and on a cost-effective basis, in both the United
States and Europe.
Get an update on the company’s progress with its cancer treatment
platform technology in the report you can read here: http://bit.ly/-NWBO-AnalystReport
Cellceutix, Inc. (OTCBB:
CTIX) is a clinical stage biopharmaceutical company developing
innovative therapies in oncology, dermatology and antibiotic
applications. The anti-cancer drug Kevetrin is currently in a Phase
1 clinical trial. Cellceutix will soon begin a Phase 2 clinical
trial with its Brilacidin-OM for the prevention and treatment of
Oral Mucositis. Their anti-psoriasis drug Prurisol has recently
completed a Phase 1 clinical trial and is being readied for a Phase
2 trial. Cellceutix's key antibiotic, Brilacidin, has completed a
Phase 2b trial for Acute Bacterial Skin and Skin Structure
Infections.
The company has a new COO. Read about his recent comments about
company operations in the report that follows: http://bit.ly/-CTIX-AnalystReport
Castle Brands, Inc. (NYSE-MKT:
ROX) is a developer and international marketer of premium
beverage alcohol brands including: Gosling's Rum, Jefferson's,
Jefferson's Presidential Select and Jefferson's Reserve Bourbon,
Jefferson's Rye Whiskey, Knappogue Castle Whiskey, Clontarf Irish
Whiskey, Pallini Limoncello, Boru Vodka and Brady's Irish Cream,
Celtic Honey Liqueur and Castello Mio Sambuca.
The company discussed its financial results for the first quarter
of their 2015 fiscal year. Get the report here: http://bit.ly/-ROX-AnalystReport
Special Profile can be viewed by rewading one of the previous
reports.
Disclosure: Small Cap Traders has no positions in any stocks
mentioned, and no plans to initiate any positions within the next
72 hours.
The information contained herein is not intended to be investment
advice and does not constitute any form of invitation or inducement
to engage in investment activity. Neither the information nor any
opinion expressed constitutes a solicitation for the purchase or
sale of any security. Securities, financial instruments,
strategies, or commentary mentioned herein may not be suitable for
all investors and this material is not intended for any specific
investor and does not take into account an investor’s particular
investment objectives, financial situations or needs. Any opinions
expressed herein are given in good faith, are subject to change
without notice, and are only current as of the stated date of their
issue. Prices, values, or income from any securities or investments
mentioned in this report may fluctuate, and an investor may, upon
selling an investment lose a portion of, or the entire principal
amount invested. Past performance is no guarantee of future
results. Before acting on any recommendation in this material, you
should consider whether it is suitable for your particular
circumstances and, if necessary, seek professional advice.
FORWARD-LOOKING STATEMENT
This report may contain certain forward-looking statements and
information, as defined within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934, and is subject to the Safe Harbor created by those
sections. This material contains statements about expected future
events and/or financial results that are forward-looking in nature
and subject to risks and uncertainties. Such forward- looking
statements by definition involve risks, uncertainties and other
factors, which may cause the actual results, performance or
achievements of mentioned company to be materially different from
the statements made herein.
This report was prepared for informational purposes only.
Affiliated parties involved with producing and issuing this report
have not been compensated in any form. A full disclaimer can be
found by viewing the full analyst report.
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Northwest Biotherapeutics (QB) (USOTC:NWBO)
Historical Stock Chart
From Sep 2023 to Sep 2024